Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial.
about
Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progression-free and overall s ...... in a randomized phase 2 trial.
@en
Progression-free and overall s ...... in a randomized phase 2 trial.
@nl
type
label
Progression-free and overall s ...... in a randomized phase 2 trial.
@en
Progression-free and overall s ...... in a randomized phase 2 trial.
@nl
prefLabel
Progression-free and overall s ...... in a randomized phase 2 trial.
@en
Progression-free and overall s ...... in a randomized phase 2 trial.
@nl
P2093
P2860
P1476
Progression-free and overall s ...... in a randomized phase 2 trial.
@en
P2093
A Alvarez Secord
C M Michener
P2860
P2888
P356
10.1186/S40425-016-0137-X
P577
2016-06-21T00:00:00Z
P6179
1033181369